ArticleCancers2023

Immune Checkpoint Inhibitors Targeting the PD-1/PD-L1 Pathway in Advanced, Recurrent Endometrial Cancer: A Scoping Review with SWOT Analysis.

Racheal Louise Johnson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.